# Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System

Study · id `cardio:ct-nct05120193` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05120193](<https://clinicaltrials.gov/study/NCT05120193>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05120193

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 477 participants.

## Technical summary

Registry record NCT05120193. Randomized; single masking; primary purpose treatment. Start 2021-12-14 (actual); primary completion 2024-01-10 (actual). Results posted on 2025-02-03.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 477 participants (enrolled count; ClinicalTrials.gov record NCT05120193, source copy `cardio:ctgov-nct05120193-2025-04-23`, retrieved 2026-10-26)
- Started: 2021-12-14 (actual) (ClinicalTrials.gov record NCT05120193, source copy `cardio:ctgov-nct05120193-2025-04-23`, retrieved 2026-10-26)
- Primary completion: 2024-01-10 (actual) (ClinicalTrials.gov record NCT05120193, source copy `cardio:ctgov-nct05120193-2025-04-23`, retrieved 2026-10-26)
- Completion: 2024-01-10 (actual) (ClinicalTrials.gov record NCT05120193, source copy `cardio:ctgov-nct05120193-2025-04-23`, retrieved 2026-10-26)
- Results first posted: 2025-02-03 (ClinicalTrials.gov record NCT05120193, source copy `cardio:ctgov-nct05120193-2025-04-23`, retrieved 2026-10-26)
- Countries: United States; Czechia; Israel (ClinicalTrials.gov record NCT05120193, source copy `cardio:ctgov-nct05120193-2025-04-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05120193-2025-04-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System
- Acronym: SPHERE Per-AF
- Condition: Atrial Fibrillation
- Intervention (Device): Mapping and Ablation
- Lead sponsor: Medtronic Cardiac Ablation Solutions
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Ablation Solutions (`cardio:org-medtronic-cardiac-ablation-solutions`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial (`cardio:pubmed-38760584`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Operator learning curve with a novel dual-energy lattice-tip ablation system (`cardio:pubmed-39922404`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of linear ablation in persistent atrial fibrillation using a dual-energy, wide-footprint catheter: Analysis from the SPHERE Per-AF randomized trial (`cardio:pubmed-41655663`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8daad0e2017437979a26afc85c71dddc0ed687653421a18a84752f48d5b54bec
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
